Novavax (NVAX) Net Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Novavax (NVAX) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Novavax | 1.67 Bn | 951.85 Mn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,406.00 |
| Mar 31, 2026 | 4,300.00 |
| Dec 31, 2025 | 7,540.00 |
| Sep 30, 2025 | -16,163.00 |
| Jun 30, 2025 | 9,382.00 |
| Mar 31, 2025 | 84,369.00 |
| Dec 31, 2024 | 26,932.00 |
| Sep 30, 2024 | 57,637.00 |
| Jun 30, 2024 | 121,856.00 |
| Mar 31, 2024 | 92,782.00 |
| Dec 31, 2023 | 74,391.00 |
| Sep 30, 2023 | 50,603.00 |
| Jun 30, 2023 | 42,756.00 |
| Mar 31, 2023 | 11,746.00 |
| Dec 31, 2022 | 43,776.00 |
| Sep 30, 2022 | 51,125.00 |
| Jun 30, 2022 | 38,592.00 |
| Mar 31, 2022 | 80,117.00 |
| Sep 30, 2021 | 205,825.00 |
| Jun 30, 2021 | 150,096.00 |